01 1Cadila Pharmaceuticals
01 1HYDRALAZINE HYDROCHLORIDE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2020-08-12
Pay. Date : 2020-07-01
DMF Number : 34945
Submission : 2020-07-03
Status : Active
Type : II
20
Cadila Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is HYDRALAZINE HYDROCHLORIDE USP, with a corresponding US DMF Number 34945.
Remarkably, this DMF maintains an Active status since its submission on July 03, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 12, 2020, and payment made on July 01, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II
